{
    "medicine_id": "b2e91ae86507d3e3e84c94e5aff687c01e3836ff",
    "platform_id": "DB11186",
    "metadata": {
        "name": "C Tanna 12D Suspension 10 mg Syrup",
        "composition": "10 mg Pentoxyverine",
        "clinical_particulars": {
            "therapeutic_indications": "Indicated as a cough suppressant to relieve cough caused by the common cold flu bronchitis and sinusitis A32160",
            "contraindications": {
                "disease": "Acute oral LD50 is 810 mg kg in rat and 230 mg kg in mouse MSDS",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Pentoxyverine induces an antitussive action In animal studies intraperitoneal administration of pentoxyverine inhibited citric acid induced cough in guinea pigs _in vivo_ A32715 Some mice and rat studies suggest that pentoxyverine may also exert anticonvulsant activities without inducing a protective effect from NMDA induced lethality A32717 A32719 Protective effects against maximal electroshock induced seizures in a dose related fashion was also observed following either intraperitoneal or oral administration A32719 In hERG transfected cells pentoxyverine inhibited the outward current of the hERG ion channel with half maximal inhibition concentrations IC50 of 3 0 \u00b5M A32714 In rats receiving intrathecal administration pentoxyverine exhibited dose dependent spinal blockade with a more sensory selective action over motor blockade A32720 It induced a spinal blockade with a more sensory nociceptive selective action over motor blockade compared to lidocaine A32720",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}